Track topics on Twitter Track topics that are important to you
Melinta is Malin’s second largest investment by capital committed Definitive agreement entered into with Cempra, Inc. Expected positive returns driven by the value of the combined equity over time Combined company will be called Melinta Therapeutics Company will be a … Continue reading
Cet article Malin Investee Company – Melinta Therapeutics – To Be Transformed into a NASDAQ Listed Company est apparu en premier sur Biotech 365.NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...